Add BrightSurf on Google Email

Desensitisation approaches effective against hayfever-like allergies

A new Cochrane Systematic Review finds sublingual immunotherapy significantly reduces symptoms of allergic rhinitis and medication requirements. The treatment has very few serious adverse effects and is effective in children, offering a convenient alternative to injection immunotherapy.

SourceWiley·JournalCochrane Database of Systematic Reviews·DateDec 7, 2010

Carbon nanotubes boost cancer-fighting cells

Researchers at Yale University found that carbon nanotubes cause T cell antigens to cluster in high concentrations, stimulating the body's natural immune response. This breakthrough could improve current adoptive immunotherapy for cancer treatment by increasing T cell proliferation.

SourceYale University·JournalLangmuir·DateApr 20, 2010

Warning sign for potential anti-cancer approach

A new study suggests that stimulating human lung cancer cells with TLR7 or TLR8 agonists can lead to increased tumor cell survival and resistance to chemotherapy. This approach is being investigated as an adjuvant for anticancer immunotherapies, but caution should be exercised due to these potential risks.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 8, 2010

Drinking milk to ease milk allergy?

Researchers found that gradually increasing doses of milk protein over time can help children with severe and persistent milk allergy tolerate the allergen, reducing symptoms and building tolerance. The study suggests oral immunotherapy may be a promising treatment option for food allergies.

SourceJohns Hopkins Medicine·JournalJournal of Allergy and Clinical Immunology·DateOct 30, 2008

Children with serious insect-sting allergies should get shots to avoid life-threatening reactions

Researchers found that children who received venom allergy shots had significantly fewer life-threatening reactions when restung, even years later. Dr. Rebecca Gruchalla recommends the shots for kids with severe allergic reactions to insect stings, which are responsible for at least 40 fatal stings per year.

SourceUT Southwestern Medical Center·JournalNew England Journal of Medicine·DateAug 11, 2004

Adjuvant chemotherapy for colon cancer offers no survival benefit after 10 years

A randomized clinical trial showed that adjuvant chemotherapy and immunotherapy for colon cancer patients offer no disease-free or overall survival benefits after 10 years. The improvements in 5-year survival rates observed in the past have disappeared over time, suggesting that newer chemotherapy regimens may be more effective.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateAug 3, 2004

Potential allergy vaccine boosts hope for sufferers

Researchers at the University of Melbourne have developed a potential allergy vaccine using a modified rye grass protein that reduces allergenic response while boosting immune system. The vaccine, delivered in its pure form, may significantly reduce risk of anaphylactic shock and increase immunotherapy efficacy.

SourceUniversity of Melbourne·JournalEuropean Journal of Immunology·DateFeb 6, 2002